TRAUMA CARE
Educational Objectives
| The goals of this program are to improve transportation of the trauma patient (by providing better pain relief) and to
improve anesthetic care in closed head injury. After hearing and assimilating this program, the clinician will be better
able to:
|
 | 1. Review military medical advances and determine their importance for civilian trauma care.
|
 | 2. Compare challenges faced during civilian disasters with challenges seen on the battlefield (specifically, acute
pain relief and multimodal analgesia).
|
 | 3. Review the epidemiology and pathophysiology of traumatic brain injury.
|
 | 4,. Describe the role of anesthesia care in resuscitation of the injured brain.
|
 | 5. Discuss brain protection after closed head injury.
|
Faculty Disclosure
In adherence to ACCME Standards for Commercial Support, Audio-Digest requires all faculty and members of the planning committee
to disclose relevant financial relationships within the past 12 months that might create any personal conflicts of interest.
Any identified conflicts were resolved to ensure that this educational activity promotes quality in health care and not a proprietary
business or commercial interest. For this program, the faculty and planning committee reported nothing to disclose.
Acknowledgements
Dr. Buckenmaier spoke in New York, NY, at the 61st annual Postgraduate Assembly in Anesthesiology, held December
7-11, 2007, and sponsored by the New York State Society of Anesthesiologists, Inc; Dr. Wass, in Phoenix, AZ, at
the Mayo Clinic Symposium on Anesthesia and Perioperative Medicine 2008, held February 20-23, 2008, and sponsored
by the Mayo College of Medicine, School of Continuing Medical Education, Scottsdale, AZ. The Audio-Digest
Foundation thanks the speakers and the sponsors for their cooperation in the production of this program.
Transporting the Trauma Patient
Chester C. Trip Buckenmaier III, MD, Assistant Professor of Anesthesiology, Uniformed Services University of the Health
Sciences; Chief, Army Regional Anesthesia and Pain Management Initiative; and Assistant Chief, Anesthesia and Operative Services,
Walter Reed Army Medical Center, Washington, DC
| Civil War: General Stonewall Jackson among first to benefit from use of field ambulance designed to carry casualties
from battlefield to hospital (previously, wounded soldier lay on battlefield, sometimes for days, until he could
be dragged to safety); those transported by field ambulance also received analgesia (eg, whiskey, morphine); Jackson
also received ether for amputation of arm, but succumbed to pneumonia and died shortly thereafter; his response
to analgesia on battlefield, what an infinite blessing
|
| Modern military: morphineused for 19th century pain control; still important for pain management today, but failing
as monotherapy; morphine suboptimal for 21st century evacuation realities; current evacuation standardsC-
141 transport aircraft probably reason for <10% died-of-wounds rate; no military in history has achieved this success
rate; penetrating wound of head, chest, or abdomen sustained during current conflict really not an issue for
military anesthesiologist, because [soldier] usually dead; advances in body armor and 6000-mile-long [intensive
care unit] ICU that weve built has allowed survival stories from soldiers who otherwise would have been killed in
action; environment still difficultcrowded, vibrating, dark, noisy, and lacks monitoring capability; usually one
nurse and 2 flight technicians managing 30 to 60 individuals per flight; in previous conflicts, nurse remained by patient
and able to administer morphine to soldier in pain; if too much morphine administered, nurse able to provide
necessary airway or remedy situation; today, soldier seen by hundreds of health care providers in short time;
speakers experienceafter deployment to Iraq in 2003, speaker quickly recognized that many technologies and
techniques learned from civilian counterparts and colleagues not being utilized in war environment; desperately
needed because of new evacuation reality
|
| Importance of military medical accomplishments in civilian practice: battlefield formerly foreign now in your
backyard; natural disasters can strike without warning; transportation infrastructure in cities can be attacked relatively
easily; Katrina disaster indicates that our ability to withstand assaults to infrastructure relatively miniscule;
during manmade or natural disaster, anesthesia provider may be called on to do the things that we do in the military;
anesthesia response, as it relates to pain, not only can influence better medical response to natural disaster, but can
have far-reaching impact on trauma victims (ie, far into recovery)
|
| Challenges during disasters: extremes of weather; terrain issues; facility and equipment considerations; logistics
(eg, moving E cylinder of O2 ); speaker and fellow soldiers believe lives saved by avoiding general anesthesia and
using 21% O2 ; these issues have real-world impact on response to disaster; number of victims in civilian trauma
relatively manageable (eg, 3-10 victims at one time), and large resource base available (eg, electricity at wall outlet,
hot and cold running water); we wrap ourselves in a cocoon of technology, almost to the point where its difficult
to hurt our patients
|
| Challenges on battlefield: in contrast, battlefield casualties may include 50 soldiers at one time; planning for casualties
competes with generals concerned about beans and bullets; caring for wounded tends to be afterthought;
good news from current conflict that United States military known for caring for wounded soldiers; have good
chance for survival; enemy also knows United States military will care for them if injured on battlefield
|
| Personal safety issues: if weapon of mass destruction (WMD) used, plan required to prevent contamination of all
hospital personnel
|
| Pain perspective: acute pain service, particularly at Walter Reed Army Medical Center, driving force behind accomplishments
in military pain management; anesthesia provider best available person to manage acute pain in hospital,
particularly after trauma; also, with expertise in regional anesthesia, anesthesia provider best able to manage trauma
in austere environment; advances may affect recovery by, eg, reducing posttraumatic stress disorder, improving return
to duty, and improving management of prosthetics; effective acute pain management likely prevents issues of
phantom limb pain and complex regional pain syndrome (CRPS); effective acute pain management is prophylactic;
changes that occur in central nervous system lead to chronic pain issues, contribute to depression and posttraumatic
stress, and prevent soldier from recovering faster and resuming role as productive member of society
|
| Multimodal analgesia: novel concept for military; morphine used for ≈200 yr; now being adopted, due to advances
in technology and forward-thinking health care providers who have worked with Walter Reeds Army Regional Anesthesia
and Pain Management Initiative and Military Advanced Regional Anesthesia and Analgesia Group; regional
anesthesia has elements necessary for battlefield, ie, leaves light logistics footprint, requires minimally
invasive equipment to perform well, and provides days to weeks (not hours) of analgesia
|
| Changes in battlefield pain relief: peripheral nerve stimulator used with every block, regardless of whether ultrasonography
(US) available; in austere conditions, easier to obtain stimulator than US; if interested in regional anesthesia,
do not forget everything learned, including paresthesia techniques; microprocessor-driven technology also
useful; can serve as patient-controlled analgesia (PCA) device and pump for epidural techniques, and can be used
for peripheral nerve blocks; catheters in place for weeks; ability to redose catheter and take soldier back to surgery
important
|
| Acute pain service: use regional anesthesia techniques as foundation upon which to build; use other narcotics, gabapentin,
and nonsteroidal anti-inflammatory drugs; internet-based system being explored that will track acute pain
patients from battlefield to hospital in Germany (recently through first approval phase); special forces in Afghanistan
given fluoroquinolone, cyclooxygenase-2 (COX-2) inhibitor, and acetaminophen (eg, Tylenol) and instructed
to take tablets if wounded; useful for disaster situation in which soldier injured and in pain; adequate pain management
will augment medical response
|
| New technologies: iontophoresis; fentanyl lollipops; infusion and monitoring technologies (eg, pulse oximetry)
|
Closed Head Injury: Anesthetic Considerations
C. Thomas Wass, MD, Associate Professor of Anesthesiology, Mayo College of Medicine, Rochester, MN
| Case: previously healthy, 25-yr-old man, extricated from drivers side of car after high-speed motor vehicle accident;
report of steering wheel deformity and starred windshield; patient semiconscious, combative, has Glasgow Coma
Scale (GCS) score of 9, exhibits midline facial fractures and bilateral black eyes, and hyperdynamic with labored
tachypnea; concerns include integrity of mediastinal and thoracic cavity structures, traumatic brain injury (TBI),
and spinal cord injury; trepidation about safely securing airway in combative patient with midline facial fractures
|
| Epidemiology: 1.4 million Americans annually sustain TBI; 1.1 million treated and released from emergency department,
230,000 hospitalized, and ≈50,000 die as result of injuries; leading cause of mortality in individuals <45 yr of
age; annual cost $60 billion in United States alone; TBI can be classified by mechanism of injury (penetrating vs
blunt), GCS score (<9 considered coma), or cerebral pathology
|
| Cerebral pathology and pathophysiology: primaryoccurs at time of impact; biomechanical dissipation of energy
onto skull and underlying brain, resulting in structural and functional changes; not modifiable; secondaryresults
from systemic or intracranial perturbations that occur minutes, hours, or days after initial trauma; anesthesia personnel
can significantly intervene to improve patient outcome; systemic causes include anything that limits O2 delivery
to brain, hyperglycemia, and fever; intracranial (IC) causes include increased IC pressure (ICP), brain
edema, IC hematoma, seizure, vasospasm, or meningitis; ultimate goal to prevent or mitigate secondary neurologic
injury
|
 | Airway: regardless of technique or route of tracheal intubation, head-injured patient should be treated as though concomitant
cervical spine injury present; in-line stabilization (rather than in-line traction) currently proposed; change
in practice stems from concerns about iatrogenic spinal cord injury associated with in-line traction (eg, stretch-related
or compression-related injury to spinal cord); safety of routine use of nasal intubation in presence of maxillofacial
injury another concern; severe midline facial fractures may be associated with anterior skull base (eg,
cribriform plate of ethmoid bone) injury; presents clinically as bilateral periorbital ecchymosis and possibly cerebrospinal
fluid (CSF) draining from nose (rhinorrhea); fractures in petrous portion of temporal bone present clinically
as postauricular ecchymosis and possibly CSF draining from ear (otorrhea); nasogastric, nasopharyngeal,
and nasotracheal tubes may traverse fracture site and enter cranial vault, resulting in hemorrhage, meningitis, cerebritis,
or frank neurologic deficit (including neurogenic death); consequently, in presence of severe maxillofacial
or known anterior skull base fracture, prudent to avoid routine nasotracheal intubation
|
 | Breathing: decreases in ICP correspond to decreases in cerebral blood volume; despite this response, aggressive hyperventilation
has been cornerstone for managing severe TBI for >20 yr; however, positron emission tomography
(PET) studies indicate aggressive hyperventilation may be associated with iatrogenic ischemia; in absence of trials
to evaluate direct effect of hyperventilation on patient outcome, Brain Trauma Foundation recommends
avoiding arterial CO2 tension (PaCO 2 ) <25 mm Hg; if using jugular bulb catheter, titrate PaCO 2 to keep jugular
venous O2 saturation >60%; if not using jugular bulb catheter, hyperventilate to 30 to 35 mm Hg
|
 | Circulation: systemic mean arterial blood pressure (MAP) main determinant of cerebral blood flow (CBF); under
normal conditions, autoregulation maintains CBF at near-constant level over wide range of cerebral perfusion
pressures (CPPs; usually 50-150 mm Hg); however, in setting of TBI or ischemia, autoregulation likely impaired
(in certain regions or in entire brain); if treatment overly aggressive, vasogenic edema may result; if not aggressive
enough, brain ischemia may result; several clinical trials suggest CPP of 60 to 70 mm Hg may be critical
threshold determining patient outcome; when CPP decreases below this level, mortality reportedly increases 20%
for each 10-mm Hg decrease in CPP; Brain Trauma Foundation recommends maintaining MAP >80 mm Hg in
attempt to preserve CPP >60 mm Hg
|
 | Neuroprotective anesthetics: numerous groups of investigators have evaluated neuroprotective efficacy of various anesthetics,
including barbiturates, etomidate, ketamine, propofol, volatile anesthetics, lidocaine, and dexmedetomidine;
of these, only barbiturates show potential clinical promise; historically touted as gold standard; shown to
significantly improve histopathology and functional neurologic outcome in focal (eg, classic stroke) or incomplete
global ischemia (eg, low cardiac output states), but not shown to be helpful in complete ischemia (eg, cardiac arrest);
despite plethora of convincing laboratory data, only one study corroborating these findings; barbiturates effective
for ICP control or in providing seizure management; considering lack of supportive human evidence,
barbiturates should not be considered neuroprotective
|
 | Calcium channel blockers and N-methyl-D -aspartate (NMDA) receptor antagonists: calcium plays vital and sinister
role in modulating neuronal injury, via voltage-gated and NMDA receptor channels; stimulation of these channels
causes massive influx of calcium into cell, leading to free radical production, lipid peroxidation, and possibly
setting into motion programmed cell death (apoptosis); calcium entry blockers and NMDA antagonists were
in phase 3 clinical trials, but studies had to be discontinued due to adverse effects; these agents should not be considered
neuroprotective
|
 | Temperature: since 1980s, numerous laboratory studies have reported that temperature decreases of 1°C to 6°C can
significantly improve neurologic outcome in either focal or global ischemia; also shown beneficial in complete ischemia;
however, clinical studies have produced conflicting reports; mild hypothermia may be beneficial if potential
systemic pitfalls known; effective for treating intractable IC hypertension; future studies may focus on selective
brain cooling (in which rest of body remains at or near normothermia); fever worsens neurologic outcome
|
 | Corticosteroids: double-edged sword; theoretically provide protective antioxidant properties; however, corticosteroids
increase gluconeogenesis and glycogenolysis, decrease end-organ sensitivity to endogenous and exogenous
insulin, and lead to hyperglycemia; 64% of trauma centers in United States surveyed use corticosteroids to
treat TBI, despite lack of supportive laboratory or human-based data; lazaroids used clinically in 1990s, but
stopped because of adverse effects; speakers laboratory found no benefit; according to Brain Trauma Foundation,
majority of available evidence indicates steroids do not improve outcome or lower ICP in severe TBI; strong
evidence that corticosteroids deleterious, thus use not recommended
|
| Summary: resuscitation of brain begins with restoration of normal systemic physiology (eg, providing ABCs of advanced
life support); in-line stabilization preferred over in-line traction during laryngoscopy; avoid routine nasal
intubation in known or suspected anterior skull base fracture; moderate hyperventilation to PaCO 2 of 30 mm Hg;
maintain CPP at 60 mm Hg; use of hypothermia unclear; avoid fever, hyperglycemia, and corticosteroids
|
Suggested Reading
Buckenmaier CC 3rd et al: Continuous peripheral nerve block in combat casualties receiving low-molecular weight heparin.
Br J Anaesth 97:874, 2006; Buckenmaier CC et al: Continuous peripheral nerve block for battlefield anesthesia and evacuation.
Reg Anesth Pain Med 30:202, 2005; Clifton GL et al: A phase II study of moderate hypothermia in severe brain injury. J
Neurotrauma 10:263, 1993; Clifton GL et al: Lack of effect of induction of hypothermia after acute brain injury. N Engl J Med
344:556, 2001; Cohen SP et al: Randomized placebo-controlled study evaluating lateral branch radiofrequency denervation for
sacroiliac joint pain. Anesthesiology 109:279, 2008; Gilbert M et al: Resuscitation from accidental hypothermia of 13.7 degrees
C with circulatory arrest. Lancet 355:375, 2000; Harris OA et al: The role of hypothermia in the management of severe brain
injury: a meta-analysis. Arch Neurol 59:1077, 2002; Henderson WR et al: Hypothermia in the management of traumatic brain
injury. A systematic review and meta-analysis. Intensive Care Med 29:1637, 2003; Marion DW et al: The use of moderate therapeutic
hypothermia for patients with severe head injuries: a preliminary report. J Neurosurg 79:354, 1993; Marion DW et al:
Treatment of traumatic brain injury with moderate hypothermia. N Engl J Med 336:540, 1997; McIntyre LA et al: Prolonged
therapeutic hypothermia after traumatic brain injury in adults: a systematic review. JAMA 289:2992, 2003; Nussmeier NA et al:
Neuropsychiatric complications after cardiopulmonary bypass: cerebral protection by a barbiturate. Anesthesiology 64:165, 1986;
Polderman KH et al: Effects of therapeutic hypothermia on intracranial pressure and outcome in patients with severe head injury.
Intensive Care Med 28:1563, 2002.
|